Incidence and Clinical Impact of Stent Fracture After Everolimus-Eluting Stent Implantation
Author(s) -
Shoichi Kuramitsu,
Masashi Iwabuchi,
Takuya Haraguchi,
Takenori Domei,
Ayumu Nagae,
Makoto Hyodo,
Kyohei Yamaji,
Yoshimitsu Soga,
Takeshi Arita,
Shinichi Shirai,
Katsuhiro Kondo,
Kenji Andò,
Koyu Sakai,
Masahiko Goya,
Yoshitaka Takabatake,
Shinjo Sonoda,
Hiroyoshi Yokoi,
Fumitoshi Toyota,
Hideyuki Nosaka,
Masakiyo Nobuyoshi
Publication year - 2012
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.112.969238
Subject(s) - medicine , stent , restenosis , myocardial infarction , everolimus , intravascular ultrasound , drug eluting stent , cardiology , surgery , radiology
Stent fracture (SF) after drug-eluting stent implantation has recently become an important concern because of its potential association with in-stent restenosis and stent thrombosis. However, the incidence and clinical impact of SF after everolimus-eluting stent implantation remain unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom